PubRank

Fuyuhiko Motoi

Author PubWeight™ 69.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 2004 2.30
2 RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005 2.11
3 Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am J Pathol 2003 1.70
4 Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells. Int J Cancer 2008 1.35
5 Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 2003 1.30
6 Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012 1.22
7 Clinicopathological aspects of small pancreatic cancer. Pancreas 2004 1.18
8 Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2009 1.18
9 Predictive risk factors for clinically relevant pancreatic fistula analyzed in 1,239 patients with pancreaticoduodenectomy: multicenter data collection as a project study of pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2011 1.18
10 Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. Oncogene 2003 1.14
11 Synchronous and metachronous extrapancreatic malignant neoplasms in patients with intraductal papillary-mucinous neoplasm of the pancreas. Pancreatology 2008 1.08
12 miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J Cell Physiol 2013 1.07
13 Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas 2007 1.04
14 Major hepatectomy for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2009 1.01
15 Up-regulation of MSX2 enhances the malignant phenotype and is associated with twist 1 expression in human pancreatic cancer cells. Am J Pathol 2008 1.01
16 Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Am J Surg Pathol 2011 1.00
17 Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis. Ann Surg 2016 1.00
18 Solid pseudopapillary neoplasms of the pancreas: an 18-year experience at a single Japanese Institution. Surg Today 2012 1.00
19 LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells. Int J Oncol 2009 0.99
20 Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients. J Gastroenterol 2014 0.97
21 DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells. Biochem Biophys Res Commun 2012 0.94
22 Effect of Hospital Volume on Surgical Outcomes After Pancreaticoduodenectomy: A Systematic Review and Meta-analysis. Ann Surg 2016 0.93
23 Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. Anticancer Res 2009 0.93
24 GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation. Cancer Lett 2012 0.93
25 Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma. Cancer Sci 2008 0.92
26 Long-period pancreatic stenting for painful chronic calcified pancreatitis required higher medical costs and frequent hospitalizations compared with surgery. Pancreas 2011 0.92
27 Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 2007 0.91
28 Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan. Pancreas 2016 0.91
29 Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study. Int J Clin Oncol 2011 0.89
30 The usefulness of endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic neuroendocrine tumors based on the World Health Organization classification. Scand J Gastroenterol 2014 0.88
31 How much of the pancreatic head should we resect in Frey's procedure? Surg Today 2009 0.88
32 The expression of S100A4 in human pancreatic cancer is associated with invasion. Pancreas 2013 0.87
33 Expression of Sonic hedgehog signaling pathway correlates with the tumorigenesis of intraductal papillary mucinous neoplasm of the pancreas. Oncol Rep 2008 0.87
34 Serous cystic neoplasms of the whole pancreas in a patient with von Hippel-Lindau disease. Intern Med 2011 0.86
35 Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues. Int J Cancer 2012 0.86
36 Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer. Pancreas 2010 0.86
37 Attenuation of phosphorylation by deoxycytidine kinase is key to acquired gemcitabine resistance in a pancreatic cancer cell line: targeted proteomic and metabolomic analyses in PK9 cells. Pharm Res 2012 0.85
38 Distal pancreatectomy (with video). J Hepatobiliary Pancreat Sci 2012 0.85
39 Infiltration of CD40-positive tumor-associated macrophages indicates a favorable prognosis in colorectal cancer patients. Hepatogastroenterology 2013 0.84
40 Cystic lymphangioma of the pancreas with spontaneous rupture: report of a case. Case Rep Gastroenterol 2011 0.84
41 Gene therapy for pancreatic cancer based on genetic characterization of the disease. J Hepatobiliary Pancreat Surg 2002 0.84
42 Clinical Characteristics and Risk Factors for the Development of Postoperative Hepatic Steatosis After Total Pancreatectomy. Pancreas 2016 0.83
43 Assessment of Frey procedures: Japanese experience. J Hepatobiliary Pancreat Sci 2009 0.83
44 Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with methyl-CpG targeted transcriptional activation" (MeTA-array). Biochem Biophys Res Commun 2011 0.83
45 Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system. J Exp Clin Cancer Res 2012 0.82
46 Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissue. Clin Proteomics 2012 0.82
47 Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. Biochem Biophys Res Commun 2013 0.82
48 Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors. Surg Today 2014 0.81
49 Safety of postoperative thromboprophylaxis after major hepatobiliary-pancreatic surgery in Japanese patients. Surg Today 2014 0.81
50 Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth. Anticancer Res 2009 0.81
51 Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection. J Gastrointest Surg 2014 0.80
52 [Successful intervention with a longitudinal pancreaticojejunostomy for chronic pancreatitis due to obstruction of the pancreatogastrostomy after pancreatoduodenectomy]. Nihon Shokakibyo Gakkai Zasshi 2010 0.79
53 Phase I trial of neoadjuvant chemoradiation with gemcitabine and surgical resection for cholangiocarcinoma patients (NACRAC study). Hepatogastroenterology 2012 0.79
54 Imaging studies of intraductal tubulopapillary neoplasms of the pancreas: 2-tone duct sign and cork-of-wine-bottle sign as indicators of intraductal tumor growth. J Comput Assist Tomogr 2012 0.79
55 ZD1839 (IRESSA) stabilizes p27Kip1 and enhances radiosensitivity in cholangiocarcinoma cell lines. Anticancer Res 2009 0.79
56 Granular cell tumor of the pancreas: A case report and review of literature. World J Gastrointest Oncol 2010 0.79
57 Computed tomography reflected endocrine function of the pancreas. J Gastrointest Surg 2010 0.79
58 Dilated papilla with mucin extrusion is a potential predictor of acute pancreatitis associated with intraductal papillary mucinous neoplasms of pancreas. Pancreatology 2013 0.79
59 [Clinicopathological aspects of pancreatic cancer]. Gan To Kagaku Ryoho 2005 0.79
60 An analysis of a second-line S-1 monotherapy for gemcitabine-refractory biliary tract cancer. Hepatogastroenterology 2012 0.79
61 Human Muse cells, non-tumorigenic pluripotent-like stem cells, have the capacity for liver regeneration by specific homing and replenishment of new hepatocytes in liver fibrosis mouse model. Cell Transplant 2016 0.78
62 Clinical experiences in the treatment of pancreatic arteriovenous malformation by total pancreatectomy with islet autotransplantation. Transplantation 2013 0.78
63 Sudden disappearance of the blood flow in a case of pancreatic acinar cell carcinoma. Intern Med 2014 0.78
64 Gene therapy for intraperitoneally disseminated pancreatic cancers by Escherichia coli uracil phosphoribosiltransferase (UPRT) gene mediated by restricted replication-competent adenoviral vectors. Int J Cancer 2002 0.78
65 GC-binding factor 2 interacts with dishevelled and regulates Wnt signaling pathways in human carcinoma cell lines. Int J Cancer 2011 0.77
66 Oncolytic virotherapy as a novel strategy for pancreatic cancer. Pancreas 2004 0.77
67 Gene therapy for pancreatic cancer targeting the genomic alterations of tumor suppressor genes using replication-selective oncolytic adenovirus. Hum Cell 2002 0.77
68 [Gene therapy for pancreatic cancer]. Gan To Kagaku Ryoho 2002 0.77
69 [Surgery for pancreatic neuroendocrine tumors]. Nihon Geka Gakkai Zasshi 2012 0.77
70 Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor. Neuroendocrinology 2015 0.77
71 Long-term outcomes after extrahepatic excision of congenital choladocal cysts: 30 years of experience at a single center. Hepatogastroenterology 2015 0.77
72 Postoperative cholestasis and cholangitis after total pancreatectomy with biliary reconstruction impair the function of autotransplanted islets. Transplantation 2013 0.76
73 Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells. Anticancer Res 2008 0.76
74 Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma. J Hepatobiliary Pancreat Surg 2007 0.76
75 Institutional indications for islet transplantation after total pancreatectomy. J Hepatobiliary Pancreat Surg 2008 0.76
76 Intraoperative ultrasound examination is useful for monitoring transplanted islets: a case report. Islets 2012 0.76
77 Feasibility Assessment of Modified FOLFOX-6 as adjuvant treatment after resection of liver metastases from colorectal cancer: analyses of a multicenter phase II clinical trial (Miyagi-HBPCOG Trial-001). Hepatogastroenterology 2015 0.76
78 One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm. BMJ Case Rep 2013 0.75
79 National Comprehensive Cancer Network Resectability Status for Pancreatic Carcinoma Predicts Overall Survival. World J Surg 2015 0.75
80 Criteria for the glucagon provocative test in the diagnosis of gastrinoma. Surg Today 2012 0.75
81 [Therapeutic strategy for neuroendocrine tumor of the rectum]. Gan To Kagaku Ryoho 2013 0.75
82 [A case report of complete pathological response of a locally advanced rectal cancer after long term chemotherapy]. Gan To Kagaku Ryoho 2014 0.75
83 [Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP]. Gan To Kagaku Ryoho 2014 0.75
84 [A case of successful R0 resection after neoadjuvant therapy for locally advanced unresectable pancreatic cancer]. Gan To Kagaku Ryoho 2013 0.75
85 Segmentectomy of the liver. J Hepatobiliary Pancreat Sci 2012 0.75
86 [Current status and future prospect of pre- and post-operative adjuvant therapy of pancreatic cancer: discussion]. Nihon Shokakibyo Gakkai Zasshi 2011 0.75
87 [A case of hypersensitivity reaction to reintroduced-oxaliplatin at the second course of oxaliplatin-based chemotherapy after neoadjuvant chemotherapy for liver metastases from colon cancer]. Gan To Kagaku Ryoho 2011 0.75
88 [A case of advanced gallbladder cancer with mediastinum lymph node metastasis successfully treated with multimodality therapy]. Gan To Kagaku Ryoho 2014 0.75
89 [A case of curatively resected locally advanced pancreatic cancer with combined resection of the portal vein and common hepatic artery after neoadjuvant chemotherapy]. Gan To Kagaku Ryoho 2013 0.75
90 [A Case of Undifferentiated Carcinoma of the Sigmoid Colon That Responded to Paclitaxel and Carboplatin Chemotherapy]. Gan To Kagaku Ryoho 2016 0.75
91 [A case of distal cholangiocarcinoma with high sensitivity to neoadjuvant chemoradiation therapy]. Gan To Kagaku Ryoho 2011 0.75
92 [A Patient with Three-Year Relapse-Free Survival after Surgical Resection for Lung and Liver Metastases of Cholangiocarcinoma]. Gan To Kagaku Ryoho 2015 0.75
93 [IV. Neoadjuvant therapy for cholangiocarcinoma]. Gan To Kagaku Ryoho 2013 0.75
94 Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest. Pancreas 2014 0.75
95 [Long-term survival case after liver resection and postoperative hepatic arterial infusion for multiple liver metastases from rectal cancer]. Gan To Kagaku Ryoho 2010 0.75
96 MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction Between Pancreatic Cancer Cells and Stellate Cells. Pancreas 2017 0.75
97 [Chemotherapy for pancreatic cancer]. Gan To Kagaku Ryoho 2003 0.75
98 Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis. Ann Surg 2017 0.75
99 [Pancreatic tumor: progress in diagnosis and treatment. Topics: I. Pancreatic carcinoma; 5. Improvements in surgical treatment]. Nihon Naika Gakkai Zasshi 2012 0.75
100 [Resection of a Huge Gastrointestinal Stromal Tumor of the Stomach Following Neoadjuvant Chemotherapy with Imatinib]. Gan To Kagaku Ryoho 2016 0.75
101 [A Successful Case of Conversion Therapy after Chemotherapy for Advanced Rectal Cancer with Inguinal Lymph Node Metastasis]. Gan To Kagaku Ryoho 2016 0.75
102 The comparative anatomy of the folds, fossas, and adhesions around the duodenojejunal flexure in mammals. Folia Morphol (Warsz) 2017 0.75
103 [Chemoradiation therapy and immunotherapy for pancreatic cancer]. Nihon Rinsho 2006 0.75
104 [Occupational cholangiocarcinoma in a printer that responded to neoadjuvant chemoradiotherapy]. Nihon Shokakibyo Gakkai Zasshi 2015 0.75
105 [A Case of Successful Stomach-Preserving Pancreaticoduodenectomy with Celiac Artery Resection after Neoadjuvant Chemoradiation Therapy for Pancreatic Cancer with Hepatic Arterial Variation]. Gan To Kagaku Ryoho 2016 0.75
106 [A 5-year survival case of locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemoradiation therapy]. Gan To Kagaku Ryoho 2012 0.75
107 Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg 2017 0.75
108 Lymph nodes metastasis is a risk factor for bone metastasis from extrahepatic cholangiocarcinoma. Hepatogastroenterology 2012 0.75
109 [Efficacy of neoadjuvant chemotherapy for pancreatic carcinoma planned resection]. Nihon Rinsho 2015 0.75
110 [A case of pathological complete response to lt. Lateral lymph node metastasis from lower rectal cancer by S-1 combined neoadjuvant chemoradiotherapy]. Gan To Kagaku Ryoho 2014 0.75
111 [A case of pancreatic cancer with local recurrence and liver metastases eight years after surgery]. Gan To Kagaku Ryoho 2014 0.75
112 [A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy]. Gan To Kagaku Ryoho 2012 0.75
113 [Total Pelvic Exenteration for Local Recurrence of Rectal Cancer Appearing 12 Years after Curative Operation-A Case Report]. Gan To Kagaku Ryoho 2015 0.75
114 [Tips and pitfalls of Frey's procedure for chronic pancreatitis]. Nihon Geka Gakkai Zasshi 2014 0.75